Dr. Cox and Dr. Strong are working to better understanding the clinical spectrum of AMOTL1-related disease and the mechanism of disease. Any information you have about patient genotypes and phenotypes is extremely helpful in this effort. Patient samples (blood, fibroblasts) for DNA, RNA-sequencing and cell lines would also be helpful.
AMOTL1